Published 2008 | Version v1

Publication Metadata-only

Difference in skin toxicity incidence between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC)

Creators: GROSSI, FRANCESCO; CATANIA, GIANLUCA; Defferrari, C; Brianti, A; Dal Bello, Mg; Pronzato, P.

Others:: Grossi, Francesco; Defferrari, C; Brianti, A; Dal Bello, Mg; Catania, Gianluca; Pronzato, P.

Additional details

Created:: April 14, 2023
Modified:: December 1, 2023